Condition

Relapsing Remitting Multiple Sclerosis clinical trials and research

• 11Clinical trials
• 11Countries

Newest Relapsing Remitting Multiple Sclerosis clinical trials

All recruiting trials (11)

• Terfenadine added to standard MS therapy in relapsing MS

  This study tests whether adding terfenadine to usual MS treatment is safe and may help reduce disease activity in adults with relapsing-remitting MS.

  Recruiting Phase 2 Tongji Hospital · Wuhan, Hubei · NCT07827716

• People with Relapsing-Remitting MS try subcutaneous ocrelizumab at their clinic

  This study looks at how satisfied people with relapsing-remitting MS feel about receiving subcutaneous ocrelizumab in routine care.

  Recruiting at 2 sites Hoffmann-La Roche · Pardubice, Pardubice Region and 1 other locations · NCT07827586

• HiHat: Rituximab Followed by Cladribine in Relapsing-Remitting MS

  This trial tests whether giving rituximab and then cladribine in sequence is safe and doable for people with relapsing-remitting MS.

  Recruiting at 3 sites Phase 2 Uppsala University · Falun and 3 other locations · NCT07517185

• SetPoint implant to promote remyelination in relapsing-remitting MS

  This study will try a small implanted vagus-nerve stimulator alongside standard MS treatments to promote remyelination in adults with relapsing-remitting MS.

  Recruiting at 9 sites SetPoint Medical Corporation · Irvine, California and 8 other locations · NCT06796504

• Examining personalized treatment for multiple sclerosis with rituximab and ocrelizumab

  This study is testing whether measuring the levels of two different medications, rituximab and ocrelizumab, can help doctors personalize treatment for people with relapsing-remitting multiple sclerosis who are just starting therapy.

  Recruiting Haukeland University Hospital · Bergen, Vestland · NCT06663111

• Understanding how B-cell therapies affect immune responses in multiple sclerosis

  This study is looking at how B-cell therapies for relapsing-remitting multiple sclerosis affect the immune system and how these changes relate to patients' health over two years.

  Recruiting Heinrich-Heine University, Duesseldorf · Düsseldorf · NCT06586177

• Comparing CT-P53 and Ocrevus for treating relapsing-remitting multiple sclerosis

  This study is testing if a new treatment called CT-P53 works as well and is as safe as Ocrevus for people with relapsing-remitting multiple sclerosis.

  Recruiting Phase 3 Celltrion · Poznan · NCT05906992

• Comparing Rituximab and Ocrelizumab for Relapsing-Remitting Multiple Sclerosis

  This study is testing whether rituximab can work just as well as ocrelizumab in helping people with relapsing-remitting multiple sclerosis manage their symptoms over two years.

  Recruiting at 9 sites Phase 3 Rennes University Hospital · Lyon, Bron and 22 other locations · NCT05758831

• Investigating markers in relapsing-remitting multiple sclerosis

  This study is testing different markers in people with relapsing-remitting multiple sclerosis to see how they can help us understand the disease better and improve treatments.

  Recruiting University of Split, School of Medicine · Split · NCT04604041

• Comparing stem cell transplant to best available therapy for treatment-resistant multiple sclerosis

  This study is testing if a stem cell transplant can help people with treatment-resistant multiple sclerosis feel better compared to the best available therapies.

  Recruiting at 19 sites Phase 3 National Institute of Allergy and Infectious Diseases (NIAID) · Palo Alto, California and 22 other locations · NCT04047628

• Investigating the safety of ixazomib for treating multiple sclerosis

  This study is testing if ixazomib can safely help people with multiple sclerosis by reducing certain markers in their spinal fluid.

  Recruiting Phase 1 Queen Mary University of London · London, Greater London · NCT03783416

Related topics

Quick answers

How many Relapsing Remitting Multiple Sclerosis clinical trials are recruiting right now?

11, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 11 countries. The most sites are in United States (2 trials), Czechia (1 trial), Slovenia (1 trial), United Kingdom (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 3: 3, Phase 2: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →